Akoya Biosciences, Inc. (AKYA) NASDAQ

1.29

-0.07(-5.15%)

Updated at July 08, 2025 04:00PM

Currency In USD

Valuation

Market Cap113.17M
Enterprise Value185.54M
P/E Ratio-1.86
PEG Ratio-0.13
Price/Sales Ratio1.13
Price/Book Ratio-10.88
Enterprise/Revenue2.25
Enterprise/EBITDA-6.05

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-0.61
Operating Margin-0.48

Management Effectiveness

Return On Assets-0.31
Return On Equity-6.72

Income Statement

Revenue81.67M
Revenue/Share1.14
Gross Profit47.88M
EBITDA-37.14M
Net Income-55.37M
Diluted EPS-1.12

Balance Sheet

Total Cash27.54M
Total Cash/Share0.55
Total Debt83.72M
Total Debt/Equity-14.22
Current Ratio0.61
Book Value Per Share-0.12

Price History

52-Week Change-34.18
52-Week High3.42
52-Week Low0.93
Moving Average 50 Days1.22
Moving Average 200 Days2.04

Statistics

Average Volume582,118
Shares Outstanding49.95M
% Held by Institutions24.46

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A